A drug that stops cancer treatments damaging ovaries could preserve patients’
fertility. Researchers at the Memorial Sloan-Kettering Cancer Center and
Massachusetts General Hospital injected a compound called
sphingosine-1-phosphate into the ovaries of mice. This prevented a lipid in the
membrane of an egg cell being converted into another lipid called ceramide and
starting a chain reaction that ends in cell suicide (Nature Medicine,
vol 6, p 1109). “If they have stopped [cell death] and produced normal embryos
from the ovaries, this is fantastic,” says Geraldine Hartshorne of the University of Warwick.
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
There has been a sudden increase in the rate of sea level rise
2
The mathematician who doesn’t exist
3
PCOS postpones perimenopause and allows pregnancies at older ages
4
A lost ancient script reveals how writing as we know it really began
5
Man destined for Alzheimer's may have been saved by accidental therapy
6
Red-light therapy does have health benefits but not the ones you think
7
Dating over 50 is probably on the rise – but we know little about it
8
Fire is spreading in the Chernobyl exclusion zone after drone crash
9
Woman in cancer remission without treatment in highly unusual case
10
Tiny 'metajets' could use light to steer sails for interstellar travel



